MEDICAL BIOTECHNOLOGY

THE INDIAN SCENARIO

Authors

  • Suma Sarojini DHARMARAM VIDHYA KSHETRAM (DVK)

Keywords:

BIOTECHNOLOGY, MEDICINE

Abstract

Medicines are indeed a boon for the suffering living being, be it an
animal or a human being. From time immemorial man has been on
the lookout for medicines to relieve pain and suffering. The field of
Biotechnology has provided solutions to many health care problems.
If at all Biotechnology has revolutionized any sector, we could tell
without doubt that it is the medical field. Indian Biotech companies
are not far behind in contributing to the world of medicine. In fact,
the Bangalore based company, BIOCON is listed one among the top
10 Biotech companies of the world.

Author Biography

Suma Sarojini, DHARMARAM VIDHYA KSHETRAM (DVK)

Dr Suma Sarojini has a Ph D in Biotechnology from the Rajiv Gandhi Centre for
Biotechnology, a DBT institute in Thiruvananthapuram, Kerala. She is currently an
Assistant Professor in the Department of Biotechnology, Christ University,
Bangalore, India. Her research interests include microbial genomics, subtractive
hybridization studies and drug resistant bacteria.

References

A. Fleming. “On Antibacterial Action of Culture of Penicillium, with Special Reference to their Use in Isolation of B. influenza,” British Journal of Experimental Pathology 10 (1929).

P. Ehrlich and A. Bertheim, “Über das salzsaure Berichte der deutschen chemischen Gesellschaft,” Berichte, 45 (1912).

S. A. Waksman, “Strain Specificity and Production of Antibiotic Substances X Characterization and Classification of Species within the Streptomyces griseus Group,” Microbiology, 45 (1959).

Bauer D. J., “The Antiviral and Synergistic Actions of Isatin Thiosemicarbazone and Certain Phenoxypyrimidines in Vaccinia Infection in Mice,” British Journal of

Experimental Pathology 36 (1955).

http://www.searo.who.int/LinkFiles/Avian_Flu_combating_emerging_diseases.pdf.

N. Naidoo, Y. Pawitan, R. Soong, D.N. Cooper, C.S. Ku, (2011) “Human Genetics and Genomics a Decade after the Release of the Draft Sequence of the Human Genome,” Human Genomics 5, 6 (2011).

http://www.biocon.com/docs/biocon_annualreport_2012.pdf.

“Indian Biotechnology — The Roadmap to the Next Decade and beyond Report,“ Life Science World (2012).

http://www.kppub.com/articles/mar2011/the_indian_biotechnology_sector- A_Review.html.

(http://top10companiesinindia.com/2013/05/30/top-10-biotechnologycompanies- in-india/).

T.V. Padma, 2007. “New Test Helps Tackle India’s Chikungunya Outbreaks,” Scidevnet, http://www.scidev.net/global/health/news/protein-change-causesvirus-

to-spread.html.

http://www.biocon.com/biocon_products_bio_BF_alzumab.asp.

http://www.ibef.org/industry/biotechnology-india.aspx.

Source -http://www.seruminstitute.com/content/products/product_list.html.

www.thehindu.com/sci-tech/...rotavirus-vaccine/article4714757.ece.

http://www.stempeutics.com/stempeucel.html.

http://www.biocon.com/docs/Biocon_Science_Top20_Employers_25Oct2013.pdf.

B. Bean, (1992) “Antiviral Therapy: Current Concepts and Practices,” Clinical Microbiology Reviews 5, 2 (1992).

http://www.academia.edu/2276198/Nanotechnology_Development_in_India_ Investigating_Ten_Years_of_Indias_Efforts_in_Capacity_Building.

D. Liang, B.S. Hsiao, B. Chu, “Functional Electrospun Nanofibrous Scaffolds for Biomedical Applications,” Advanced Drug Delivery Reviews 59 (2007) 1392-1412.

A.C. Jen, M.C. Wake, A.G. Mikos, “Hydrogels for Cell Immobilization,” Biotechnology and Bioengineering 50 (1996).

C.G. Simon, Y. Yang, S.M. Dorsey, M. Ramalingam, K. Chatterjee, “3D Polymer Scaffolds,” Methods in Molecular Biology 671 (2011).

Downloads

Published

2013-12-31

How to Cite

Sarojini, S. (2013). MEDICAL BIOTECHNOLOGY: THE INDIAN SCENARIO. Asian Horizons, 7(04), 656–666. Retrieved from https://dvkjournals.in/index.php/ah/article/view/2632